| Literature DB >> 11581386 |
S Robinson1, W A Charini, M H Newberg, M J Kuroda, C I Lord, N L Letvin.
Abstract
The ability to monitor vaccine-elicited CD8(+) cytotoxic T-lymphocyte (CTL) responses in simian immunodeficiency virus (SIV)- and simian-human immunodeficiency virus (SHIV)-infected rhesus monkeys has been limited by our knowledge of viral epitopes predictably presented to those lymphocytes by common rhesus monkey MHC class I alleles. We now define an SIV and SHIV Nef CTL epitope (YTSGPGIRY) that is presented to CD8(+) T lymphocytes by the common rhesus monkey MHC class I molecule Mamu-A*02. All seven infected Mamu-A*02(+) monkeys evaluated demonstrated this response, and peptide-stimulated interferon gamma Elispot assays indicated that the response represents a large proportion of the entire CD8(+) T-lymphocyte SIV- or SHIV-specific immune response of these animals. Knowledge of this epitope and MHC class I allele substantially increases the number of available rhesus monkeys that can be used for testing prototype HIV vaccines in this important animal model.Entities:
Mesh:
Substances:
Year: 2001 PMID: 11581386 PMCID: PMC114592 DOI: 10.1128/JVI.75.21.10179-10186.2001
Source DB: PubMed Journal: J Virol ISSN: 0022-538X Impact factor: 5.103